X-linked agammaglobulinemia should be suspected if:
A behavior that is associated with a reward will increase in frequency. This principle is based on which of the following?
When does the eruption of primary dentition typically begin?
An agonist has which of the following characteristics?
A patient presents with a right homonymous hemianopia, saccadic pursuit movements, and defective optokinetic nystagmus. Where is the lesion most likely located?
General visceral afferent innervation to the posterior most aspect of the tongue is provided by which nerve?
Panniculus adiposus is seen in which of the following locations?
What are Gitter cells?
Platelet adhesion to collagen is mediated by which of the following?
Which of the following cells are MHC class II positive, except?
Explanation: **Explanation:** **X-linked Agammaglobulinemia (XLA)**, also known as Bruton’s Agammaglobulinemia, is a primary immunodeficiency caused by a mutation in the **BTK (Bruton Tyrosine Kinase) gene**. This defect leads to a failure of Pre-B cells to differentiate into mature B cells. **1. Why Option A is Correct:** B cells are the primary constituents of the germinal centers in lymphoid tissues. In XLA, there is a near-total absence of mature B cells and serum immunoglobulins. Consequently, secondary lymphoid organs that depend on B-cell proliferation—such as the **tonsils, adenoids, and peripheral lymph nodes**—are hypoplastic or absent. The clinical absence of tonsils in a child with recurrent sinopulmonary infections is a classic diagnostic hallmark. **2. Why Incorrect Options are Wrong:** * **Option B:** As the name implies, it is an **X-linked recessive** disorder, meaning it almost exclusively affects **males**. * **Option C:** Isohemagglutinins (e.g., Anti-A, Anti-B) are naturally occurring IgM antibodies. Since B cells are absent in XLA, patients cannot produce immunoglobulins, leading to **absent or low** isohemagglutinin titers. * **Option D:** CD3 is a marker for **T cells**. In XLA, T-cell numbers and functions are typically **normal**. The defect is specific to the B-cell lineage (CD19/CD20). **High-Yield Clinical Pearls for NEET-PG:** * **Genetic Defect:** BTK gene mutation on the X chromosome (Xq21.3-22). * **Clinical Presentation:** Recurrent infections with encapsulated bacteria (*S. pneumoniae, H. influenzae*) starting after 6 months of age (once maternal IgG wanes). * **Diagnosis:** Flow cytometry showing absent B cells (CD19+) and low levels of all Ig classes (IgG, IgA, IgM). * **Contraindication:** Live attenuated vaccines (e.g., OPV) are contraindicated due to the risk of vaccine-associated paralytic polio.
Explanation: The principle described—that a behavior followed by a reward (reinforcement) increases in frequency—is the core tenet of **Operant Conditioning**, a fundamental concept in **Behavior Therapy**. This was famously developed by B.F. Skinner, who demonstrated that consequences (rewards or punishments) modify the probability of a behavior recurring. In clinical practice, behavior therapy focuses on observable actions and uses techniques like positive reinforcement to encourage healthy habits and extinction to eliminate maladaptive ones. **Analysis of Incorrect Options:** * **Mindfulness Therapy:** Focuses on non-judgmental awareness of the present moment and emotional regulation rather than conditioning behavior through rewards. * **Psychodynamic Therapy:** Based on Freudian principles, it focuses on unconscious conflicts, childhood experiences, and defense mechanisms rather than behavioral reinforcement. * **Cognitive Therapy:** Focuses on identifying and restructuring distorted thought patterns (cognitions) that lead to negative emotions, based on the premise that "thoughts influence feelings." **Clinical Pearls for NEET-PG:** * **Classical Conditioning (Pavlov):** Learning through association (e.g., a bell associated with food leads to salivation). * **Operant Conditioning (Skinner):** Learning through consequences (Rewards/Punishments). * **Systematic Desensitization:** A behavior therapy technique used for phobias based on reciprocal inhibition. * **Token Economy:** A common clinical application of operant conditioning where patients earn "tokens" (rewards) for desired behaviors.
Explanation: **Explanation:** The eruption of primary (deciduous) dentition is a key milestone in pediatric development and neuroanatomy. The correct answer is **6 months**. **1. Why 6 months is correct:** The first tooth to erupt is typically the **mandibular central incisor**, which usually appears between **6 to 10 months** of age. While there is individual variation, 6 months is the standard clinical benchmark used in medical examinations. The primary dentition consists of 20 teeth in total, and the eruption process is generally completed by 2.5 to 3 years of age. **2. Analysis of Incorrect Options:** * **A & B (6 and 12 weeks):** These timeframes are far too early for tooth eruption. However, they are significant in embryology; odontogenesis (tooth development) begins around the **6th week of intrauterine life** with the formation of the dental lamina. * **D (12 months):** While some infants may experience delayed eruption, 12 months is considered late for the *start* of the process. If no teeth have erupted by 13 months, it is clinically defined as "delayed eruption," which may warrant investigation into nutritional or endocrine factors (e.g., rickets or hypothyroidism). **3. NEET-PG High-Yield Pearls:** * **Sequence of Eruption:** Central Incisor → Lateral Incisor → First Molar → Canine → Second Molar (Note: The first molar erupts *before* the canine). * **The "Rule of 4":** Starting at 7 months, approximately 4 teeth erupt every 4 months (7 months = 4 teeth; 11 months = 8 teeth; 15 months = 12 teeth, etc.). * **Permanent Dentition:** Typically begins at **6 years** with the eruption of the **1st Molar** (often called the "6-year molar"). * **Calcification:** All primary teeth begin calcifying in utero (14–18 weeks).
Explanation: **Explanation** In pharmacology and neuroanatomy, the interaction between a ligand and a receptor is defined by two key properties: **Affinity** (the ability of a drug to bind to a receptor) and **Intrinsic Activity/Efficacy** (the ability of a drug to activate the receptor and produce a biological response). **Why Option A is Correct:** An **Antagonist** (often referred to as a "blocker") possesses **affinity** for the receptor, allowing it to occupy the binding site. However, it has an **intrinsic activity of 0**. This means it does not trigger any conformational change to activate the receptor; instead, it simply prevents an agonist from binding, thereby inhibiting its effect. **Analysis of Incorrect Options:** * **Option B (Intrinsic Activity of 1):** This describes a **Full Agonist**. These drugs bind to the receptor and produce the maximum possible biological response. * **Option C (Intrinsic Activity of -1):** This describes an **Inverse Agonist**. These drugs bind to the same receptor as an agonist but produce a response that is pharmacologically opposite to that of the agonist (only possible in receptors with constitutive activity). * **Partial Agonists** (not listed) have an intrinsic activity between 0 and 1. **NEET-PG High-Yield Pearls:** 1. **Competitive Antagonism:** Shifts the Dose-Response Curve (DRC) to the **right**, increasing the $ED_{50}$ but maintaining the same $V_{max}$ (can be overcome by increasing agonist concentration). 2. **Non-competitive Antagonism:** Flattens the DRC, decreasing the $V_{max}$ (cannot be overcome by more agonist). 3. **Key Example:** Naloxone is a competitive antagonist at opioid receptors, used to reverse respiratory depression in overdose cases.
Explanation: ### Explanation The clinical triad of **right homonymous hemianopia**, **saccadic (cogwheel) pursuit**, and **defective optokinetic nystagmus (OKN)** localized to the same side is pathognomonic for a lesion in the **Parietal Lobe** (specifically the non-dominant or dominant posterior parietal cortex). **1. Why the Parietal Lobe is Correct:** * **Homonymous Hemianopia:** The optic radiations (specifically the superior fibers/Baum’s loop) pass through the parietal lobe. A lesion here results in a contralateral inferior quadrantanopia or a complete homonymous hemianopia if the entire radiation is involved [1, 2]. * **Defective OKN:** The parietal lobe contains the centers for **smooth pursuit** eye movements. When a patient is tested with an OKN drum, the "slow phase" (pursuit) is generated by the parietal cortex. A lesion here abolishes the slow phase when the drum is moved *toward* the side of the lesion, leading to an asymmetrical or absent OKN response. * **Saccadic Pursuit:** Because smooth pursuit is impaired, the eyes attempt to track moving objects using a series of small, jerky "catch-up" saccades (cogwheel movements) [2]. **2. Why Other Options are Incorrect:** * **Frontal Lobe:** Primarily involved in **saccadic** eye movements (Frontal Eye Fields). Lesions cause a deviation of eyes *toward* the side of the lesion but do not typically cause hemianopia or OKN defects [2]. * **Occipital Lobe:** While it causes homonymous hemianopia (often with macular sparing), it does not typically disrupt the OKN response unless the parietal pursuit pathways are also involved [1]. * **Temporal Lobe:** Lesions here involve **Meyer’s loop**, leading to a contralateral "pie in the sky" (superior quadrantanopia), not the OKN defects seen in parietal lesions. **High-Yield Clinical Pearls for NEET-PG:** * **Parietal Lobe:** "Pie on the floor" (Inferior quadrantanopia) + Abnormal OKN. * **Temporal Lobe:** "Pie in the sky" (Superior quadrantanopia) + Normal OKN. * **Rule of Thumb:** If a question mentions **OKN defects** alongside visual field loss, always look for the **Parietal Lobe**.
Explanation: The sensory innervation of the tongue is a high-yield topic in neuroanatomy, categorized by the embryological origin of its different parts. ### **Explanation of the Correct Answer** The tongue is divided into three main anatomical zones for sensory innervation: 1. **Anterior 2/3rd:** Derived from the 1st pharyngeal arch. 2. **Posterior 1/3rd:** Derived from the 3rd pharyngeal arch [1]. 3. **Posterior-most aspect (Vallecula/Epiglottic region):** Derived from the **4th pharyngeal arch**. The **Vagus nerve (CN X)**, specifically via its **internal laryngeal branch**, provides both General Visceral Afferent (GVA - touch/pain) and Special Visceral Afferent (SVA - taste) innervation to the posterior-most aspect of the tongue and the epiglottic region [1]. ### **Why Other Options are Incorrect** * **Glossopharyngeal nerve (CN IX):** Provides both general and special sensation to the **posterior 1/3rd** of the tongue (including the circumvallate papillae) [1]. It is the nerve of the 3rd arch. * **Facial nerve (CN VII):** Provides special sensation (taste) to the **anterior 2/3rd** via the chorda tympani. It does not provide general sensation to the tongue. * **Trigeminal nerve (CN V3):** The lingual nerve (a branch of the mandibular division) provides general sensation (GVA) to the **anterior 2/3rd** of the tongue. ### **High-Yield Clinical Pearls for NEET-PG** * **Circumvallate Papillae:** Although located anterior to the sulcus terminalis, they are innervated by the **Glossopharyngeal nerve (CN IX)** [1]. * **Motor Innervation:** All muscles of the tongue (intrinsic and extrinsic) are supplied by the **Hypoglossal nerve (CN XII)**, EXCEPT the **Palatoglossus**, which is supplied by the **Vagus nerve (CN X)** via the pharyngeal plexus. * **Gag Reflex:** Afferent limb is CN IX; Efferent limb is CN X.
Explanation: **Explanation:** **Panniculus adiposus** refers to the fatty layer of the subcutaneous tissue (superficial fascia). While this layer is present over most of the body, it is notably **absent** in specific regions where skin mobility or thinness is essential. **Why Orbit is Correct:** The **Orbit** contains a significant amount of specialized adipose tissue (orbital fat) that acts as a cushion for the eyeball and facilitates its smooth movement. Unlike the other options listed, the orbit is a primary site where fat accumulation is physiologically necessary. **Why Other Options are Incorrect:** * **Scrotum & Penis:** In these regions, the panniculus adiposus is replaced by smooth muscle fibers. In the scrotum, this is the **Dartos muscle**, which helps in thermoregulation. The absence of fat ensures the testes remain at a temperature lower than the core body temperature. * **Eyelid:** The skin of the eyelid is the thinnest in the body. It lacks subcutaneous fat (panniculus adiposus) to allow for rapid, effortless blinking and to prevent bulkiness that would obstruct vision. **High-Yield Facts for NEET-PG:** * **Fat-free zones:** The panniculus adiposus is absent in the **eyelids, penis, scrotum, and the auricle of the ear.** * **Clinical Pearl:** In the abdomen, the panniculus adiposus is well-developed and is known as **Camper’s fascia**. * **Surgical Importance:** When suturing, the superficial fascia (panniculus adiposus) must be distinguished from the deeper membranous layer (Scarpa’s fascia) to ensure proper wound closure.
Explanation: **Explanation:** **Gitter cells** are the activated, phagocytic form of **microglia** [1]. Microglia are the resident immune cells of the Central Nervous System (CNS), derived from the embryonic yolk sac (mesodermal origin) [1]. When the brain tissue undergoes injury, such as liquefactive necrosis in an ischemic stroke [3], microglia migrate to the site of damage. They ingest necrotic debris and lipids, becoming enlarged, globular, and vacuolated [1]. These lipid-laden macrophages are specifically termed "Gitter cells" (from the German word *Gitter*, meaning "lattice," referring to their perforated appearance). **Analysis of Options:** * **Option A (Correct):** Gitter cells are specifically transformed microglia that act as the primary scavengers of the CNS [1]. * **Option B (Incorrect):** While Gitter cells function *as* macrophages, they are specifically derived from resident microglia in the CNS [1], whereas the term "modified macrophages" is too broad and usually refers to systemic histiocytes (like Kupffer cells or Alveolar macrophages). * **Option C (Incorrect):** Astrocytes are the "repair" cells of the CNS. They form the blood-brain barrier and create the "glial scar" (gliosis) after injury, but they do not transform into Gitter cells [1]. * **Option D (Incorrect):** Neutrophils are the first responders in acute inflammation but do not become Gitter cells. **High-Yield NEET-PG Pearls:** * **Origin:** Microglia are the only glial cells of **mesodermal** origin (Astrocytes and Oligodendrocytes are ectodermal/neuroepithelial) [1]. * **Function:** They are the CNS equivalent of the Reticuloendothelial system [2]. * **Stain:** Microglia can be visualized using **silver carbonate** stains. * **Clinical Context:** Gitter cells are most prominently seen in the "Organization" stage of a brain infarct (approx. 3–7 days post-stroke) [3].
Explanation: The process of primary hemostasis begins with **platelet adhesion**, where platelets attach to the exposed subendothelial matrix following vascular injury [1]. **Why Von Willebrand Factor (vWF) is correct:** When the endothelium is damaged, subendothelial collagen is exposed. **Von Willebrand Factor (vWF)** acts as a molecular bridge between the exposed collagen and the platelets [1]. Specifically, vWF binds to the **GP Ib-IX-V receptor** complex on the platelet surface. This interaction is crucial, especially under conditions of high shear stress (like in arteries), to tether platelets to the site of injury. **Analysis of Incorrect Options:** * **Factor VIII (A):** While vWF acts as a carrier protein for Factor VIII in the circulation to prevent its degradation, Factor VIII itself is a cofactor in the intrinsic pathway of the coagulation cascade (secondary hemostasis) and does not mediate initial adhesion. * **Factor IX (B):** This is a serine protease of the intrinsic pathway. Its deficiency leads to Hemophilia B (Christmas disease). It is involved in thrombin generation, not initial platelet-collagen binding. * **Fibronectin (D):** While fibronectin is an adhesive glycoprotein found in the extracellular matrix and plasma that can assist in cell adhesion, it is not the primary mediator of platelet-collagen adhesion in the high-flow environment of the vasculature. **High-Yield Clinical Pearls for NEET-PG:** * **Bernard-Soulier Syndrome:** Caused by a deficiency of the **GP Ib** receptor; characterized by giant platelets and failure of platelet adhesion. * **Von Willebrand Disease (vWD):** The most common inherited bleeding disorder; results in impaired adhesion and a secondary decrease in Factor VIII levels. * **Ristocetin Cofactor Assay:** Used to test vWF function; ristocetin induces platelet agglutination only in the presence of vWF.
Explanation: The expression of **MHC Class II molecules** is restricted to specific cells of the immune system known as **Professional Antigen-Presenting Cells (pAPCs)**. These molecules are essential for presenting exogenous antigens to CD4+ T-helper cells [2]. **Why T cells is the correct answer:** Resting **T cells** do not express MHC Class II molecules. While activated T cells in humans can occasionally express them, they are generally categorized as the "targets" of MHC II presentation rather than the presenters. In the context of standard medical examinations, T cells are the classic "except" when discussing constitutive MHC II expression [2]. **Analysis of incorrect options:** * **B cells:** These are professional APCs [2]. They internalize antigens via their B-cell receptors and present them via MHC II to T-helper cells to receive signals for antibody production [5]. * **Macrophages:** These are key professional APCs. After phagocytosing pathogens, they process proteins into peptides and display them on MHC II molecules to initiate the adaptive immune response [1]. * **Platelets:** While traditionally viewed only as hemostatic fragments, recent high-yield research confirms that platelets express MHC Class I and, in certain inflammatory states, can express **MHC Class II**, acting as non-professional APCs. However, in most standard MCQ formats, if T cells are an option, they remain the primary answer as they are the effector cells, not the presenting cells. **NEET-PG High-Yield Pearls:** * **MHC Class I:** Found on **all nucleated cells** (and platelets) [3]. It presents endogenous antigens to CD8+ T cells. * **MHC Class II:** Found on **Professional APCs** (B cells, Macrophages, Dendritic cells) and thymic epithelial cells [1], [4]. * **Dendritic Cells:** The most potent professional APCs required to activate "naive" T cells [1]. * **Rule of 8:** MHC II × CD4 = 8; MHC I × CD8 = 8.
Organization of the Nervous System
Practice Questions
Spinal Cord Anatomy
Practice Questions
Brainstem Anatomy
Practice Questions
Cerebellum
Practice Questions
Diencephalon
Practice Questions
Cerebral Cortex
Practice Questions
Basal Ganglia
Practice Questions
Limbic System
Practice Questions
Cranial Nerves
Practice Questions
Autonomic Nervous System
Practice Questions
Neural Pathways and Tracts
Practice Questions
Neurovascular Anatomy
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free